← All organizations
Highest phase reached
Phase 3
First clinical trial
May 28, 2019Last known activity
Sep 4, 2024
Acquired by Novo Nordisk on Oct 15, 2025
Timeline
2010s
- Jun 1, 2017
Akero Therapeutics, Inc— Founded
2020s
- Oct 15, 2025
Novo Nordisk— Acquired By
Drugs by trial phase (2 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT06528314Lead sponsorPhase 3Sep 4, 2024
- NCT06215716Lead sponsorPhase 3Dec 1, 2023
- NCT06161571Lead sponsorPhase 3Nov 10, 2023
- NCT05039450Lead sponsorPhase 2Jul 30, 2021
- NCT04767529Lead sponsorPhase 2Feb 16, 2021
- NCT03976401Lead sponsorPhase 2May 28, 2019
Details
- Founded
- South San Francisco, CA, US Jun 1, 2017
- Last known activity
- Sep 4, 2024